Skip to content

Common Stock at other companies

TriSalus Life Sciences, Inc. logo
TriSalus Life Sciences, Inc.TLSI
400M0.0%
Globus Medical logo
Globus MedicalGMED

Other financials

Income statement

See full
Revenue$5.3M+104%
Gross profit$3.8M+107%
Operating income-$8.0M+28.2%
Net income-$7.1M+34.2%
EPS (diluted)$0.19-47.2%

Balance sheet

See full
Cash & equivalents$50.3M+8.3%
Total debt$7.5M+52.8%
Total equity$59.4M+17.0%
Total assets$73.5M+20.7%

Cash flow

See full
Operating cash flow-$8.6M-3.6%
CapEx$44.0K
Free cash flow-$9.6M

Valuation

See full
Market cap$241.65M+33.9%
Enterprise value$198.81M+32.5%
P/S12.8×-2.4×

Profitability

See full
Gross margin71.1%+3.4pp
Operating margin-202.6%-51.3pp
Net margin-206.8%-39.0pp
FCF margin-238.4%

Returns & leverage

See full
Return on equity-70.6%+4.8pp
Debt / equity0.1×0.0×
Current ratio6.6×-4.8×

Where this comes from

Reported directly by Profound Medical in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Profound Medical's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Profound Medical's common stock?
Profound Medical (PROF) reported common stock of $324.16M in Q1 2026.
How has Profound Medical's common stock changed year-over-year?
Profound Medical's common stock increased by 15.1% year-over-year, from $281.64M to $324.16M.
What is the long-term trend for Profound Medical's common stock?
Over 2 years (2023 to 2025), Profound Medical's common stock has grown at a 20.7% compound annual growth rate (CAGR), from $222.21M to $323.84M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).